Market Place
Sourcing Support
New Certification for HTL Biotechnology
01 Oct 2024 //
PRESS RELEASE
HTL Biotechnology Secures Medical Device Registration in China
05 Jul 2024 //
PRESS RELEASE
HTL Biotechnology at CPHI China 2024
21 Jun 2024 //
PRESS RELEASE
HTL Biotechnology New Ecovadis Gold label 2024
05 Jun 2024 //
PRESS RELEASE
BIOPHTA 6.5 million Euros Seed Funding
03 Jun 2024 //
PRESS RELEASE
Acquisition of the Modern Meadow’s human recombinant collagen platform
06 May 2024 //
PRESS RELEASE
90 years of Hyaluronic Acid with HTL Biotechnology
15 Feb 2024 //
PRESS RELEASE
HTL launches new CSR strategy
09 Oct 2023 //
PRESS RELEASE
BMG & HTL sign a devp agreement to manufacture BMG’s Hyaluromimethic® Technology
14 Sep 2023 //
PRESS RELEASE
HTL team in Korea and China to meet their clients and expend business
14 Mar 2023 //
PRESS RELEASE
HTL, winner of the special jury prize at the CCI France International Trophy
28 Jun 2022 //
PRESS RELEASE
HTL accelerates its development strategy with the appointment of François Fournier as CEO from Sep 1st, 2022
08 Jun 2022 //
PRESS RELEASE
HTL Announces Its Incubator`s Equity Investment In GelMEDIX
10 Mar 2022 //
PRNEWSWIRE
HTL announces Montagu as new investor alongside its historical shareholders, Naxicap and Téthys Invest
28 Feb 2022 //
PRESS RELEASE
HTL launches a new, cutting-edge bioproduction unit for pharmaceutical-grade biopolymers
30 Sep 2021 //
PRESS RELEASE
Eirion Therapeutics Announces Strategic Agreement for HTL Biotechnology
08 Sep 2021 //
PRNEWSWIRE
Terasaki Institute for Biomedical Innovation and HTL Biotechnology
07 May 2021 //
PR NEWSWIRE
HTL Biotechnology, Echelon Biosciences Announce Strategic Partnership
16 Apr 2021 //
PHARMTECH
LabCom GELMECS, a new shared laboratory for biomaterials in regenerative medicine
10 Dec 2020 //
PRESS RELEASE
HTL is protecting the safety of its employees and its facility
20 Mar 2020 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.